Verve Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ALPHABET INC. | 02/07/2025 | 12.35 M | $69.65 M | 0.00% | 14.66% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 7.53 M | $42.44 M | 3.42% | 8.93% |
| BVF INC/IL | 02/14/2025 | 6.90 M | $38.94 M | 962.16% | 8.20% |
| VANGUARD GROUP INC | 02/11/2025 | 4.01 M | $22.60 M | 0.04% | 4.76% |
| CASDIN CAPITAL, LLC | 02/14/2025 | 4.00 M | $22.54 M | 0.00% | 4.74% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 3.92 M | $22.10 M | -21.04% | 4.65% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 3.79 M | $21.37 M | 57.42% | 4.50% |
| NOVO HOLDINGS A/S | 02/14/2025 | 2.40 M | $13.54 M | 0.00% | 2.85% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 2.35 M | $13.27 M | -2.99% | 2.79% |
| ARCH VENTURE MANAGEMENT, LLC | 02/14/2025 | 2.01 M | $11.33 M | 0.00% | 2.39% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 1.69 M | $9.54 M | 0.00% | 2.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.63 M | $9.17 M | 1.57% | 1.93% |
| FMR LLC | 02/13/2025 | 1.42 M | $7.99 M | -0.16% | 1.68% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.39 M | $7.86 M | 100.00% | 1.66% |
| REDMILE GROUP, LLC | 02/14/2025 | 1.32 M | $7.43 M | -4.71% | 1.57% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 1.32 M | $7.42 M | -21.29% | 1.56% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 1.25 M | $7.05 M | 0.00% | 1.48% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 741,179 | $4.18 M | -29.28% | 0.88% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 645,000 | $3.64 M | 22.86% | 0.77% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 635,847 | $3.59 M | 14.46% | 0.75% |
| PALO ALTO INVESTORS LP | 02/14/2025 | 575,817 | $3.25 M | 0.00% | 0.68% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 570,718 | $3.22 M | -0.25% | 0.68% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 570,304 | $3.22 M | 32.54% | 0.68% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 437,089 | $2.46 M | 1.23% | 0.52% |
| JPMORGAN CHASE & CO | 02/12/2025 | 417,539 | $2.35 M | -74.66% | 0.50% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 363,400 | $2.05 M | -36.78% | 0.43% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 361,498 | $2.04 M | 4.17% | 0.43% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 350,000 | $1.97 M | 0.00% | 0.42% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 293,200 | $1.65 M | 58.83% | 0.35% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 291,383 | $1.64 M | 100.00% | 0.35% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 258,873 | $1.46 M | 14.52% | 0.31% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 231,123 | $1.30 M | -11.92% | 0.27% |
| BARCLAYS PLC | 02/13/2025 | 220,731 | $1.24 M | -0.98% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 220,502 | $1.24 M | 2.44% | 0.26% |
| ALGERT GLOBAL LLC | 02/14/2025 | 188,005 | $1.06 M | -16.15% | 0.22% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 169,991 | $958,748 | -0.01% | 0.20% |
| ACUTA CAPITAL PARTNERS, LLC | 02/14/2025 | 160,200 | $903,528 | 9.65% | 0.19% |
| JANE STREET GROUP, LLC | 02/14/2025 | 156,228 | $881,126 | -27.97% | 0.19% |
| JUMP FINANCIAL, LLC | 02/13/2025 | 147,819 | $833,698 | 26.17% | 0.18% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 144,749 | $815,845 | 16.48% | 0.17% |
| STIFEL FINANCIAL CORP | 02/13/2025 | 141,142 | $796,041 | 7.41% | 0.17% |
| UBS GROUP AG | 02/14/2025 | 139,789 | $788,409 | -14.83% | 0.17% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 139,159 | $785,000 | 285.46% | 0.17% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 136,417 | $769,392 | -35.33% | 0.16% |
| SWISS NATIONAL BANK | 02/10/2025 | 133,100 | $750,684 | 15.64% | 0.16% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 127,464 | $718,897 | 12.26% | 0.15% |
| PFM HEALTH SCIENCES, LP | 02/14/2025 | 125,999 | $710,634 | 0.00% | 0.15% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 119,818 | $675,774 | 4.15% | 0.14% |
| CITIGROUP INC | 02/12/2025 | 118,434 | $667,968 | 109.80% | 0.14% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 117,600 | $663,264 | -82.67% | 0.14% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Verve Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 189 institutional investors and hedge funds held shares of Verve Therapeutics, Inc.. The most heavily invested institutionals were:
Alphabet Inc.: 12.35 M
BlackRock Funding, Inc. /DE: 7.53 M
BVF INC/IL: 6.9 M
VANGUARD GROUP INC: 4.01 M
Casdin Capital, LLC: 4 M
MILLENNIUM MANAGEMENT LLC: 3.92 M
93.39% of Verve Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 82.71 M shares in the last 24 months. This purchase volume represents approximately $530.18 M in transactions.